SPDR S&P Pharmaceuticals ETF (XPH): Price and Financial Metrics ETF
XPH Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
Current price | $41.21 | 52-week high | $48.76 |
Prev. close | $41.09 | 52-week low | $35.22 |
Day low | $40.74 | Volume | 44,694 |
Day high | $41.36 | Avg. volume | 53,342 |
50-day MA | $41.89 | Dividend yield | 1.61% |
200-day MA | $43.80 |
XPH Stock Price Chart Interactive Chart >
SPDR S&P Pharmaceuticals ETF (XPH) ETF Bio
The investment objective of the SPDR S&P Pharmaceuticals ETF is to provide investment results that correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index.
XPH ETF Info
Issuer | State Street Global Advisors |
Expense Ratio | 0.35% |
Underlying Index | S&P Pharmaceuticals Select Industry Index |
Asset Class | Equity |
Sector | Health & Biotech ETFs |
Assets Under Management (AUM) | 147.77M |
Net Asset Value (NAV) | $41.05 |
Options? | Yes |
Total Holdings | 45 |
XPH Top Holdings
Symbol | Company | % of Total |
CORT | CORCEPT THERAPEUTICS INC | 5.2% |
LLY | ELI LILLY + CO | 4.31% |
TARS | TARSUS PHARMACEUTICALS INC | 4.05% |
RPRX | ROYALTY PHARMA PLC CL A | 4% |
JNJ | JOHNSON + JOHNSON | 3.85% |
ZTS | ZOETIS INC | 3.83% |
PBH | PRESTIGE CONSUMER HEALTHCARE | 3.72% |
PRGO | PERRIGO CO PLC | 3.7% |
ELAN | ELANCO ANIMAL HEALTH INC | 3.69% |
PFE | PFIZER INC | 3.62% |
XPH Price Returns
1-mo | -5.91% |
3-mo | -9.63% |
6-mo | -10.09% |
1-year | 5.16% |
3-year | 4.31% |
5-year | 7.63% |
YTD | -3.81% |
2024 | 4.94% |
2023 | 2.97% |
2022 | -9.83% |
2021 | -10.54% |
2020 | 14.68% |
XPH Dividends
Ex-Dividend Date | Type | Payout Amount | Change | ||||||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |